Last update 05 Aug 2025

QLF32101

Overview

Basic Info

Drug Type
Biological products
Synonyms
QLF 32101, QLF-32101, QLF32101
Target-
Action-
Mechanism-
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Inactive Indication-
Originator Organization
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.
Active Organization
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with QLF32101
NCT05703204
/ Unknown statusPhase 1
A Phase 1 Clinical Study on the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
100 Clinical Results associated with QLF32101
Login to view more data
100 Translational Medicine associated with QLF32101
Login to view more data
100 Patents (Medical) associated with QLF32101
Login to view more data
100 Deals associated with QLF32101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 1
China
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.
01 Feb 2023
Myelodysplastic SyndromesPhase 1
China
Qilu Pharmaceutical Co., Ltd.Qilu Pharmaceutical Co., Ltd.
01 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT05703204 (EHA2024)
ManualManual
Phase 1
Acute Myeloid Leukemia
CLL1 positive | CD3
11
QLF32101 0.36-18 ug
poswjzezru(wkzshsbqss) = zafvupslio xeygyefkvy (teocigrzzy )
View more
Positive
14 May 2024
poswjzezru(wkzshsbqss) = sxmvqpqbiy xeygyefkvy (teocigrzzy )
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free